These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 15293094
1. Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Amital H, Applbaum YH, Vasiliev L, Rubinow A. Clin Rheumatol; 2004 Aug; 23(4):330-2. PubMed ID: 15293094 [Abstract] [Full Text] [Related]
2. The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA). Speden D, Nicklason F, Francis H, Ward J. Aust N Z J Med; 1997 Jun; 27(3):307-10. PubMed ID: 9227815 [Abstract] [Full Text] [Related]
13. Reversible hypertrophic osteoarthropathy associated with cyanotic congenital heart disease. Frand M, Koren G, Rubinstein Z. Am J Dis Child; 1982 Aug; 136(8):687-9. PubMed ID: 7102619 [Abstract] [Full Text] [Related]
14. Late signs of cyanotic congenital cardiac disease. Marijon E, Ferreira B, Ou P. Cardiol Young; 2006 Apr; 16(2):193-4. PubMed ID: 16553986 [No Abstract] [Full Text] [Related]
15. Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience. Sonthalia N, Mukherjee K, Saha A, Talukdar A. BMJ Case Rep; 2012 Nov 11; 2012():. PubMed ID: 23148395 [Abstract] [Full Text] [Related]
17. Hypertrophic osteoarthropathy in cyanotic congenital heart disease: its prevalence and relationship to bypass of the lung. Martínez-Lavín M, Bobadilla M, Casanova J, Attié F, Martínez M. Arthritis Rheum; 1982 Oct 11; 25(10):1186-93. PubMed ID: 7138592 [Abstract] [Full Text] [Related]